{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:51:00Z","timestamp":1793407860565,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s00259-010-1666-z","type":"journal-article","created":{"date-parts":[[2010,12,2]],"date-time":"2010-12-02T06:33:53Z","timestamp":1291271633000},"page":"711-721","source":"Crossref","is-referenced-by-count":35,"title":["Human biodistribution and radiation dosimetry of novel PET probes targeting the deoxyribonucleoside salvage pathway"],"prefix":"10.1007","volume":"38","author":[{"given":"Johannes","family":"Schwarzenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caius G.","family":"Radu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Benz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Fueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Q.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Phelps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen N.","family":"Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagichettiar","family":"Satyamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Czernin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiaan","family":"Schiepers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,3]]},"reference":[{"key":"1666_CR1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncponc1041","volume":"5","author":"W Weber","year":"2008","unstructured":"Weber W, Grosu A, Czernin J. Technology Insight: advances in molecular imaging and an appraisal of PET\/CT scanning. Nat Clin Pract Oncol 2008;5:160\u201370.","journal-title":"Nat Clin Pract Oncol"},{"key":"1666_CR2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","volume":"59","author":"A Jemal","year":"2009","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1666_CR3","first-page":"29","volume-title":"Cancer drug discovery and development: deoxynucleoside analogs in cancer therapy","author":"M Staub","year":"2006","unstructured":"Staub M, Eriksson S. The role of deoxycytidine kinase in DNA synthesis and nucleoside analog synthesis. In: Peters GJ, editor. Cancer drug discovery and development: deoxynucleoside analogs in cancer therapy. Totowa: Humana; 2006. p. 29\u201352."},{"key":"1666_CR4","doi-asserted-by":"crossref","unstructured":"Kulke MH, Tempero MA, Niedzwiecki D, Hollis DR, Kindler HL, Cusnir M, et al. Randomized phase II study of gemcitabine administered at a fixed dose rate or in combination with cisplatin, docetaxel, or irinotecan in patients with metastatic pancreatic cancer: CALGB 89904. J Clin Oncol 2009;27:5506\u201312. doi: 10.1200\/JCO.2009.22.1309 .","DOI":"10.1200\/JCO.2009.22.1309"},{"key":"1666_CR5","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/JTO.0b013e3181a9a020","volume":"4","author":"R Lilenbaum","year":"2009","unstructured":"Lilenbaum R, Villaflor VM, Langer C, O\u2019Byrne K, O\u2019Brien M, Ross HJ, et al. Single-agent versus combination chemotherapy in patients with advanced non-small cell lung cancer and a performance status of 2: prognostic factors and treatment selection based on two large randomized clinical trials. J Thorac Oncol 2009;4:869\u201374. doi: 10.1097\/JTO.0b013e3181a9a020 .","journal-title":"J Thorac Oncol"},{"key":"1666_CR6","first-page":"138","volume":"1776","author":"LP Jordheim","year":"2007","unstructured":"Jordheim LP, Dumontet C. Review of recent studies on resistance to cytotoxic deoxynucleoside analogues. Biochim Biophys Acta 2007;1776:138\u201359. doi: 10.1016\/j.bbcan.2007.07.004 .","journal-title":"Biochim Biophys Acta"},{"key":"1666_CR7","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nm1724","volume":"14","author":"CG Radu","year":"2008","unstructured":"Radu CG, Shu CJ, Nair-Gill E, Shelly SM, Barrio JR, Satyamurthy N, et al. Molecular imaging of lymphoid organs and immune activation by positron emission tomography with a new [18F]-labeled 2'-deoxycytidine analog. Nat Med 2008;14:783\u20138.","journal-title":"Nat Med"},{"key":"1666_CR8","doi-asserted-by":"crossref","unstructured":"Laing RE, Walter MA, Campbell DO, Herschman HR, Satyamurthy N, Phelps ME, et al. Noninvasive prediction of tumor responses to gemcitabine using positron emission tomography. Proc Natl Acad Sci U S A 2009;106:2847\u201352.","DOI":"10.1073\/pnas.0812890106"},{"key":"1666_CR9","doi-asserted-by":"crossref","first-page":"6522","DOI":"10.1038\/onc.2008.316","volume":"27","author":"B Ewald","year":"2008","unstructured":"Ewald B, Sampath D, Plunkett W. Nucleoside analogs: molecular mechanisms signaling cell death. Oncogene 2008;27:6522\u201337. doi: 10.1038\/onc.2008.316 .","journal-title":"Oncogene"},{"key":"1666_CR10","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/01.cco.0000245326.65152.af","volume":"18","author":"V Gandhi","year":"2006","unstructured":"Gandhi V, Plunkett W. Clofarabine and nelarabine: two new purine nucleoside analogs. Curr Opin Oncol 2006;18:584\u201390. doi: 10.1097\/01.cco.0000245326.65152.af00001622-200611000-00007 .","journal-title":"Curr Opin Oncol"},{"key":"1666_CR11","doi-asserted-by":"crossref","unstructured":"Shu CJ, Campbell DO, Lee JT, Tran AQ, Wengrod JC, Witte ON, et al. Novel PET probes specific for deoxycytidine kinase. J Nucl Med 2010;51:1092\u20138. doi: 10.2967\/jnumed.109.073361 .","DOI":"10.2967\/jnumed.109.073361"},{"key":"1666_CR12","first-page":"2816","volume":"33","author":"DH Ho","year":"1973","unstructured":"Ho DH. Distribution of kinase and deaminase of 1-beta-D-arabinofuranosylcytosine in tissues of man and mouse. Cancer Res 1973;33:2816\u201320.","journal-title":"Cancer Res"},{"key":"1666_CR13","doi-asserted-by":"crossref","unstructured":"Maury G. The enantioselectivity of enzymes involved in current antiviral therapy using nucleoside analogues: a new strategy? Antivir Chem Chemother 2000;11:165\u201389.","DOI":"10.1177\/095632020001100301"},{"key":"1666_CR14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00004728-199401000-00023","volume":"18","author":"K Wienhard","year":"1994","unstructured":"Wienhard K, Dahlbom M, Eriksson L, Michel C, Bruckbauer T, Pietrzyk U, et al. The ECAT EXACT HR: performance of a new high resolution positron scanner. J Comput Assist Tomogr 1994;18:110\u20138.","journal-title":"J Comput Assist Tomogr"},{"key":"1666_CR15","unstructured":"Loevinger R, Budinger TF, Watson EE, Society of Nuclear Medicine (1953- ). Medical Internal Radiation Dose Committee. MIRD primer for absorbed dose calculations (revised edition). New York: Society of Nuclear Medicine; 1991."},{"key":"1666_CR16","first-page":"1023","volume":"46","author":"MG Stabin","year":"2005","unstructured":"Stabin MG, Sparks RB, Crowe E. OLINDA\/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 2005;46:1023\u20137. doi: 46\/6\/1023 .","journal-title":"J Nucl Med"},{"key":"1666_CR17","unstructured":"ICRP. Radiation dose to patients from radiopharmaceuticals. ICRP Publication 53. Approved by the Commission in March 1987. Elmsford: Pergamon; 1988."},{"key":"1666_CR18","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2967\/jnumed.108.056036","volume":"50","author":"WE Bolch","year":"2009","unstructured":"Bolch WE, Eckerman KF, Sgouros G, Thomas SR. MIRD pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry\u2014standardization of nomenclature. J Nucl Med 2009;50:477\u201384 doi: 10.2967\/jnumed.108.056036 .","journal-title":"J Nucl Med"},{"key":"1666_CR19","doi-asserted-by":"crossref","unstructured":"ICRP. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP 2007;37:1\u2013332. doi: 10.1016\/j.icrp.2007.10.003 .","DOI":"10.1016\/j.icrp.2007.10.003"},{"key":"1666_CR20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2967\/jnumed.107.044453","volume":"49","author":"C Schiepers","year":"2008","unstructured":"Schiepers C, Hoh CK, Nuyts J, Seltzer M, Wu C, Huang SC, et al. 1-11C-acetate kinetics of prostate cancer. J Nucl Med 2008;49:206\u201315. doi: 10.2967\/jnumed.107.044453 .","journal-title":"J Nucl Med"},{"key":"1666_CR21","unstructured":"FDA. 21CFR361 - Code of Federal Regulations Title 21 Part 361 Section\u00a01. HHS; 1975 (revised April 1, 2010)."},{"key":"1666_CR22","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1182\/blood-2003-06-2122","volume":"103","author":"S Jeha","year":"2004","unstructured":"Jeha S, Gandhi V, Chan KW, McDonald L, Ramirez I, Madden R, et al. Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia. Blood 2004;103:784\u20139. doi: 10.1182\/blood-2003-06-2122 .","journal-title":"Blood"},{"key":"1666_CR23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.0105-2896.2005.00275.x","volume":"205","author":"DD Taub","year":"2005","unstructured":"Taub DD, Longo DL. Insights into thymic aging and regeneration. Immunol Rev 2005;205:72\u201393. doi: 10.1111\/j.0105-2896.2005.00275.x .","journal-title":"Immunol Rev"},{"key":"1666_CR24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00280-005-0037-0","volume":"57","author":"H Sun","year":"2006","unstructured":"Sun H, Collins JM, Mangner TJ, Muzik O, Shields AF. Imaging the pharmacokinetics of [F-18]FAU in patients with tumors: PET studies. Cancer Chemother Pharmacol 2006;57:343\u20138. doi: 10.1007\/s00280-005-0037-0 .","journal-title":"Cancer Chemother Pharmacol"},{"key":"1666_CR25","doi-asserted-by":"crossref","unstructured":"ICRP. Radiation dose to patients from radiopharmaceuticals. Addendum 3 to ICRP Publication 53. ICRP Publication 106. Approved by the Commission in October 2007. Ann ICRP 2008;38:1\u2013197. doi: 10.1016\/j.icrp.2008.08.003 .","DOI":"10.1016\/j.icrp.2008.08.003"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00259-010-1666-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T15:02:21Z","timestamp":1559833341000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-010-1666-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,3]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["1666"],"URL":"https:\/\/doi.org\/10.1007\/s00259-010-1666-z","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,3]]}}}